EE444 Cost of Childhood Rsv Management and Cost-Effectiveness of Rsv Interventions in Low- and Middle-Income Countries: A Systematic Review

New RSV vaccines and mAbs in late-stage trials show promising clinical effectiveness, however evidence of economic value and affordability must also be considered if these interventions are to be accessible in LMICs where the burden is greatest. This systematic review’s objective was to summarise existing evidence on cost-of-illness and cost-effectiveness of RSV prevention interventions for children in LMICs.